Acyclovir Auxilto Cream Use In Pregnancy & Lactation

Pregnancy: No studies have been conducted concerning use of Acyclovir Auxilto Cream 5% w/w during pregnancy; however, records of use of acyclovir formulations during pregnancy have not revealed any increase in the number of malformations, compared to the general population. Additionally, the malformations observed showed no unique characteristics or consistent patterns suggestive of a common cause.
Although systemic exposure to acyclovir following topical application of Acyclovir Auxilto Cream 5% w/w is very low, Acyclovir Auxilto Cream 5% w/w use by pregnant women should only be considered when the potential benefits outweigh possible unknown risks.
Lactation: No studies have been conducted concerning use of Acyclovir Auxilto Cream 5% w/w during lactation; however, limited data in humans reveal that acyclovir is excreted in human milk following systemic administration. Although the dose received by a nursing infant following maternal use of Acyclovir Auxilto Cream 5% w/w would be negligible, Acyclovir Auxilto Cream 5% w/w use during lactation should only be considered when the potential benefits outweigh possible unknown risks.